Several zinc‐containing matrix‐degrading endopeptidases (MMP‐1, MMP‐2, MMP‐3), which are known regulators of tissue remodeling in aging and cancer, were also included in the selected list of metformin targets. The gene discussed is MMP3; the disease is cancer.